Christopher Horan
Chief Tech Operations Officer
Common Stock
- Reported value
- $70.7K
- Reported price
- $6.8372 / share
Artiva Biotherapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $813.01K by 4 insiders.
Showing the first 6 of 20 trades on this page.
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
$28,803,280 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & Head of R&D
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & Head of R&D
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Tech Operations Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Tech Operations Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
COO, CLO, Compliance Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Tech Operations Officer | Common StockSale | 10,340$6.84 / share | $70.7K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,370$6.84 / share | $57.23K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale | 1,099$6.84 / share | $7.51K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale | 61,696$6.84 / share | $421.83K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockGrant or award | 110,000Award · no purchase price | Non-cash award | Sep 15Filed Sep 15 · 0d later | SEC filing |
| Chief Executive Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units315,000Award · no purchase price | Non-cash award | Sep 15Filed Sep 15 · 0d later | SEC filing |
| Chief Executive Officer | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Chief Executive Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units155,000Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| +5Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| President & Head of R&D | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| President & Head of R&D | Employee Stock Option (Right to Buy)Grant or award | Derivative units135,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Tech Operations Officer | Common StockGrant or award | 40,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Tech Operations Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units120,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
Showing the latest 20 of 71 trades. Show all 71 trades
This reflects the filings imported so far, not a complete trading history.